Abstract
A requirement for scaffolding complexes containing internalized G protein-coupled receptors and β-arrestins in the activation and subcellular localization of extracellular signal-regulated kinases 1 and 2 (ERK1/2) has recently been proposed. However, the composition of these complexes and the importance of this requirement for function of ERK1/2 appear to differ between receptors. Here we report that substance P (SP) activation of neurokinin-1 receptor (NK1R) stimulates the formation of a scaffolding complex comprising internalized receptor, β-arrestin, src, and ERK1/2 (detected by gel filtration, immunoprecipitation, and immunofluorescence). Inhibition of complex formation, by expression of dominant-negative β-arrestin or a truncated NK1R that fails to interact with β-arrestin, inhibits both SP-stimulated endocytosis of the NK1R and activation of ERK1/2, which is required for the proliferative and antiapoptotic effects of SP. Thus, formation of a β-arrestin-containing complex facilitates the proliferative and antiapoptotic effects of SP, and these effects of SP could be diminished in cells expressing truncated NK1R corresponding to a naturally occurring variant.
Bibliography
DeFea, K. A., Vaughn, Z. D., OâBryan, E. M., Nishijima, D., Déry, O., & Bunnett, N. W. (2000). The proliferative and antiapoptotic effects of substance P are facilitated by formation of a β-arrestin-dependent scaffolding complex. Proceedings of the National Academy of Sciences, 97(20), 11086â11091.
References
34
Referenced
342
10.1002/(SICI)1097-4547(19980515)52:4<483::AID-JNR12>3.0.CO;2-4
10.1126/science.270.5240.1326
10.1038/36362
10.1083/jcb.148.6.1267
10.1126/science.283.5402.655
10.1038/376781a0
10.1523/JNEUROSCI.19-01-00056.1999
10.1074/jbc.274.18.12333
10.1091/mbc.9.8.2305
10.1074/jbc.274.23.16257
10.1073/pnas.94.17.9475
10.1074/jbc.272.4.2363
10.1091/mbc.6.5.509
10.1523/JNEUROSCI.16-21-06975.1996
-
K S Quinlan, I S Song, S M Naik, E L Letran, J E Olerud, N W Bunnett, C A Armstrong, S W Caughman, J C Ansel J Immunol 162, 1656–1661 (1999).
(
10.4049/jimmunol.162.3.1656
) / J Immunol by Quinlan K S (1999) 10.1152/ajpcell.1998.275.6.C1580
10.1021/bi00832a044
10.1074/jbc.272.31.19125
10.1074/jbc.274.20.13978
10.1016/S1040-7952(97)80024-9
10.1128/MCB.18.2.790
10.1074/jbc.274.30.20989
10.1074/jbc.274.21.14893
10.1038/383547a0
10.1161/01.HYP.33.1.201
10.1093/molehr/4.12.1099
10.1016/S0092-8674(00)81589-5
10.1074/jbc.271.36.21898
10.1016/S0896-6273(00)80173-7
10.1074/jbc.273.4.1839
10.1016/S0092-8674(00)81189-7
10.1083/jcb.142.3.625
10.1016/0026-2862(90)90024-L
10.4049/jimmunol.164.5.2479
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 10:32 a.m.) |
Deposited | 2 years, 4 months ago (April 22, 2023, 8:07 a.m.) |
Indexed | 6 days, 1 hour ago (Aug. 29, 2025, 6:33 a.m.) |
Issued | 24 years, 11 months ago (Sept. 19, 2000) |
Published | 24 years, 11 months ago (Sept. 19, 2000) |
Published Online | 24 years, 11 months ago (Sept. 19, 2000) |
Published Print | 24 years, 11 months ago (Sept. 26, 2000) |
@article{DeFea_2000, title={The proliferative and antiapoptotic effects of substance P are facilitated by formation of a β-arrestin-dependent scaffolding complex}, volume={97}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.190276697}, DOI={10.1073/pnas.190276697}, number={20}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={DeFea, K. A. and Vaughn, Z. D. and O’Bryan, E. M. and Nishijima, D. and Déry, O. and Bunnett, N. W.}, year={2000}, month=sep, pages={11086–11091} }